Nyse Order Imbalance 67935.0 Shares On Sell Side

European equities traded in the US as American depositary receipts were advancing on Monday morning, up 0.5% to 1,324.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor contract manufacturing company STMicroelectronics and Spanish bank Banco Bilbao Vizcaya Argentaria , which rose 5.5% and 2.5%, respectively.

They were followed by Spanish bank Banco Santander , which added 2.3%.

The decliners from continental Europe were led by Swedish food company Oatly and Norwegian energy company Equinor , which fell 1.1% and 0.8%, respectively.

From the UK and Ireland, the gainers were led by clinical-stage biopharmaceutical company Barinthus Biotherapeutics and biotech Compass Pathways , which rose 5.1% and 4.1%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Amarin and clinical-stage cell therapy company TC Biopharm , which were each shedding 2.2%.

These large-cap stocks were the worst performers in the last week. Are they in your portfolio?

• Target Corporation tumbled 17.83% after the company reported the third-quarter earnings miss, and analysts slashed the price target on the stock.
• Temu parent PDD Holdings Inc. plummeted 12.22% after the company reported worse-than-expected financial results. Analysts cut the price forecast on the stock.
• ZTO Express stock fell 8.50% after the company reported third-quarter results and cut its FY24 guidance for parcel volume.
• Tenet Healthcare Corporation stock dipped 7.54% after Raymond James downgraded the stock from Strong Buy to Outperform.
• Ulta Beauty, Inc. fell 7.34% after Berkshire Hathaway cut its position in the stock.
• Intuit Inc. declined 6.94% after the company reported second-quarter results. Several analysts revised the price forecasts on the stock.
• Nokia Corporation NYSE: NOK) stock decreased 6.28%. The company secured a multi-year, multi-billion USD contract extension with Bharti Airtel in India.
• Alibaba Group Holding Limited shares were down 6.16%. The company plans to issue U.S. dollars and Chinese yuan bonds to raise capital, repay existing debt, and support an ongoing stock buyback initiative.
• Banco Santander stock dipped 5.60%.
• Incyte Corporation stock declined 5.47% after the company announced that data from its Phase 2 study evaluating MRGPRX4 (INCB000547) in cholestatic does not support further development.

Photo via Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

European equities traded in the US as American depositary receipts were trending modestly higher late Friday morning, rising 0.19% to 1,316.54 on the S&P Europe Select ADR Index, which is up approximately 1.2% for the week.

From continental Europe, the gainers were led by biotech firm BioNTech and medical device maker EDAP TMS , which rose 3.6% and 2.6%, respectively. They were followed by internet browser company Opera and pharmaceutical company Ascendis Pharma , which were up 2.1% each.

The decliners from continental Europe were led by biopharmaceutical company Genfit and financial services company Banco Santander , which dropped 4.8% and 3.9%, respectively. They were followed by financial services companies ING and Banco Bilbao Vizcaya Argentaria , which fell 2.7% and 2%, respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics and biopharmaceutical company Amarin , which climbed 13% and 5.6% higher, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals B and pharmaceutical company AstraZeneca , which increased 5.5% and 2.9%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics and TC Biopharm , which lost 12% and 3.9%, respectively. They were followed by biotech firm Trinity Biotech and biopharmaceutical company Adaptimmune Therapeutics , which were down 3.1% and 2.5%, respectively.